VEEV B/O ON ANALYST ADVICElikely to be similar failed b/o which retests the b/o high or goes lower - would not chase here
VEEV trade ideas
Why we should not learn to time the market ?As you can see from the weekly chart, it has been going sideways since 2022 and assuming you bought it at 235 price level, the market has brought you nothing but disappointment on 3 disappointments.
You can see each time it reaches this level, the sellers are there to take profits or short it down. Will this time be different? I certainly hope so as Trump takes over the White House again....
Let's revisit the chart in a few weeks from now.
Don't buy a stock just because someone recommend itWe are all motivated to do things out of own interests, whether we know about it , admit it or not. There will be and will continue to have analysts, brokerage firms, famous gurus, coaches, myself included sharing with you a particular stock and you may be tempted to go with them.
Before you do that, I suggest you DO YOUR OWN RESEARCH no matter how convincing they sound it. Their money/profit or loss is theirs and your money/profit or loss is yours as well. They may be able to stomach say 50,000 to 200,000 dollars paper losses out of their million dollars portfolio but they have other incomes coming in - courses, books, seminars, etc.
How about you? If your main income comes from your 9-5 job and your invested capital are your hard earn money then the more you need to be triple careful about your investment decisions.
Diversification is one strategy I personally do for my own portfolio to mitigate my risks in investment. That means to spread your eggs into various industries.
The fear of missing out - this is a real fear for many who probably fear they will not be able to catch up with others in terms of wealth, assets, etc. The constant pressure from peers, colleagues, etc have an accelerating stress on your emotional well being. Plus, as men, you probably faced it more since it is said that man's role is to bring home the bacon.
WHO doesn't want to go for 2-3 trips a year ? Buy the nicest gifts for their spouse and children? Stay in a nice house with a pool and take nice instagram photos to show off ?
While all these may sound like reasons for improvement, it has to be executed at a pace that you can manage. Investment is a long term strategy not buying a lottery ticket , placing all your bets in one stock and hoping it rises meteorically . I am sure out of 10 who tried that , maybe only 1 or 2 are lucky enough to make it with the majority sucking thumb and feeling the pain of regrets for making that unwise decisions.
Greed and fear will remain the biggest emotions in our lives and it applies well in the game of investment. To stay rational is TOUGH as we are not robots devoid of emotions. We get swayed and fantasied what if ............
ALWAYS do your homework , allocate correct capital to invest (dun sell grandma to bet on your horses) and stay in the market rather than TIME the market (i paid a great price for thinking I could do that in the past, dont be like me).
Veeva Announces Fiscal 2025 First Quarter Results Shares drop 8%Veeva Systems Inc., ( NYSE:VEEV ) a leading provider of cloud solutions for the global life sciences industry, announced its fiscal 2025 first quarter results, which showed a 24% increase in revenues and a 29% increase in subscription services revenues. Operating income increased by 152% YoY to $155.2 million, while non-GAAP operating income rose by 66% YoY to $260.9 million. Net income also increased by 23% YoY to $161.7 million, while non-GAAP net income rose by 67% YoY to $247.0 million.
The company's interim CFO and Board Director, Tim Cabral, expressed confidence in the company's performance, stating that they are investing for durable growth and are committed to customer success and product excellence. The company also reported significant wins in clinical, quality, regulatory, and safety, including three top 20 biopharma wins for multiple Development Cloud applications.
Veeva Vault ( NYSE:VEEV ) Basics applications are now available, preconfigured with industry standard processes and managed by Veeva with no implementation cost, allowing emerging biotechs to start with Development Cloud earlier in their lifecycle and graduate easily to full Development Cloud as they grow. The Vault CRM Suite progress continues, with the full availability of Vault CRM for all new customers in April, and 13 CRM wins in the quarter.
Veeva ( NYSE:VEEV ) added 21 new brands for Compass Patient in the first quarter, including its first seven-figure enterprise-wide win with a top 50 biopharma. The company also signed the first Compass Prescriber and Compass National customers, providing more complete and accurate data than legacy alternatives. Veeva Link also continued to progress well, crossing the 100-customer mark, as the industry enhances engagement through real-time intelligence.
Financial outlook for Veeva ( NYSE:VEEV ) is provided for the fiscal second quarter ending July 31, 2024, with total revenues between $666 and $669 million, non-GAAP operating income between $265 and $267 million, and non-GAAP fully diluted net income per share between $1.53 and $1.54.
Technically, Veeva Vault ( NYSE:VEEV ) stock is currently oversold with a Relative Strength Index (RSI) of 17.97. The daily price chart shows a "Bearish Harami" candle stick pattern accentuating the bearish campaign.
5/30/24 - $veev - leaning +ve into print but need discount/ dip5/30/24 - vrockstar - NYSE:VEEV - have put this one on my short list of things i'd like to dip buy, even though i admit i think the risk is probably higher they beat and the stock retraces today's (software factor risk off) move. 31x PE isn't cheap. it's about 1.5x PEG at this rate - which is reasonable. 3.5% fcf yield for sales growing mid teens is reasonable too especially given the niche and moat around life sciences which puts them in a slightly more protected space at this size (~28 bn EV) than up starts or more industry general competitors. i like that. the setup isn't too obvious to me enough so that i'd punt long. if they miss i sense i'd need to reassess and learn the co a bit more. if they beat, i might actually chase it. if they beat but stock drops on tmr's inflation print if rates go higher... that's the golden spot to consider a long position.
so i'm on the sidelines but rooting for the bulls as i'd like to find an oppty to own this. but given i've sized up crm today at 30% less of the valuation on similar EPS growth and nearly 2x the fcf yield, i feel comfortable being a bit more patient here.
VEEV Bullish trendVEEV is a fundamentally very strong stock
Right now its in a bull trend so entry can be made now
Entry : Current market price i.e 207
Stop loss : 199 or 182
TP 1 : 220
TP 2 : 225
TP 3 : 230
if it breaks the 230 level then we have further upside to
255
260
265
280
The key is to hold and be aware of the resistance/support levels
The movement will be slow but slow and steady wins the race
SYMMETRICAL TRIANGLELarge symmetrical triangle with a smaller one contained inside.
It appears the last earnings report was received well.
Diagonal resistance overhead.
Possible M pattern forming. Probable Cypher or Shark, maybe a Nen-star since peak 2 is higher than peak 1 if this pattern continues to form.
The Cypher is measure with the 0 fib level at the top of the 2nd peak. The Shark is measured with the 0 at the top of the 1st peak.
No recommendation.
"It may be down the road a ways when it is your time. Think a lot"
Winston Churchill
Veeva Rallied. Now it’s Pulled BackVeeva Systems has been chopping higher since the spring. Now it may be offering an entry for dip buyers.
The first pattern on today’s chart is the rally after earnings and revenue beat consensus on August 30. VEEV is trying to stabilize at a 50 percent retracement of the move. If it succeeds, it could suggest an uptrend is in effect.
Second, the current price range is near the mid-July high. Will old resistance become new support?
Third, the software stock is attempting to hold its 21-day exponential moving average.
TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more.
Important Information
TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means.
This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates.
Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
VEEV Veeva Systems Options Ahead of EarningsAnalyzing the options chain and the chart patterns of VEEV Veeva Systems prior to the earnings report this week,
I would consider purchasing the 180usd strike price Puts with
an expiration date of 2023-9-15,
for a premium of approximately $4.50.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
VEEV PutBuy Aug-18-23 185 Puts @ 0.9 Limit to Open
Tested resistance several times, oscillator seem oversold but looks like it has more to go to the downside.
Chart Looks Decent...Similar to many other ideas - it's really starting to look like so many tech stocks have huge moves yet to come in them...and this is only the beginning of a multi year melt up.
$VEEV with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $VEEV after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 66.67%.
Veeva SystemsThis is a daily chart of Veeva Systems (VEEV), a healthcare technology company that provides cloud solutions for the global life sciences industry.
When the company reported its earnings on August 31st the stock price subsequently gapped down, as shown in the chart above. From a probability standpoint, this gap is likely to be filled for the reasons below.
1. The gap is a monthly candle gap and these usually close.
Unfilled gaps on the monthly charts are generally quite rare, especially for assets that have never left a monthly gap before. As shown in the chart below, VEEV has never left a gap on its monthly chart before.
2. The gap is below the lower regression channel line. A regression channel is used to measure how far above or below an asset is trading from its mean. Since price generally tends to mean revert, it's highly unlikely that a gap below the lower channel line, (which in this case represents two standard deviations below the mean), will never be filled. It's more likely that the gap will not only be filled, but will be filled quite rapidly. The assumption I make in using this regression channel is that it is statistically valid and data are normally distributed. If true, then there's only a small probability that VEEV's monthly candle will close the month so far below the lower line of the regression channel. Therefore, it's likely that price will be drawn back up to the mean, and thus the gap will be filled.
Here's a close up view:
3. Price gapped below an important Fibonacci level that has been holding, and likely will continue to hold, as support. See the chart below.
Here are some close up views:
At a minimum, price will very likely push back into the 180s.
The quarterly chart shows long lower wicks at this Fibonacci level, indicating that it is holding as support. With further momentum to the downside waning as shown by the Stochastic RSI, there's little reason to believe this Fibonacci level will fail this time.
The lower wicks on the quarterly candles are also bouncing off of the exponential moving average (EMA) ribbon, which usually acts as support when price descends to it from above.
Strategy
With this said, I noticed that someone is already sweeping the call options. They swept hundreds of out-of-the-money (OTM) call options expiring on 9/16 with a $180 strike. Clearly, this buyer believes that VEEV's price is poised to quickly return at least to the Fibonacci support level of $180.97.
If you don't know what an options sweep is, it simply refers to an instance in which options are purchased right at the ask price. In most cases, buyers place a limit buy at the mid point of the bid-ask spread or at a lower target price. Market participants usually only buy at the ask price if they're in a rush to buy and/or if they have a high confidence about a certain market move and want to guarantee their entry while also not tipping the market off about their anticipated market move. Sweeps can also refer to when a large buyer wants to obfuscate their entry by splitting their large order into a lot of smaller parts to sweep the entire order book without tipping off the market as they would have if they placed a single large limit order. Understanding sweeps can help you understand what smart money is doing. It's very rare that retail traders sweep the order book because it's very expensive, and for a smaller portfolio (less than a million) it can be extremely risky. Therefore, smart money is usually the market participant who sweeps the order book.
Personally, I find this call sweep to be risky (assuming that it's not part of some kind of a hedge) since although we have a high confidence that the gap may close, we don't know within what time frame it will do so. Rather than sweeping a call option with a strike price of $180 that expires on 9/16 a safer though less lucrative trade would be to sell a cash-secured put with a strike price of $180 and which expires on 9/16. Doing this gives you much higher odds of winning but is profit limited.
If the price goes to $180 or higher at expiration, you win the full premium since the put you sold will not be exercised.
If the price is below $180 but above the breakeven price at expiration, or if the price is below even your breakeven price, then you may be forced to buy shares of VEEV at $180, but you can simply hold those shares until the gap closes (or longer if you think price is going higher). Therefore in this case you still do not lose money, and still make the premium as profit.
The only plausible scenario whereby you would lose money would be if VEEV's price continued to plummet and never recovers. Although this would be incredibly unlikely, it is still possible. You can nonetheless still hedge against even this risk by using a put spread to limit loss potential to a ratio that meets your risk management strategy. Therefore you can safely take a very high probability trade while managing risks well. Successful trading is mostly determined by how well you manage risks.
Finally, since options are leveraged, one should always try to time their entry as perfectly as possible by using shorter timeframe (hourly or 4-hour) charts, especially if the option's expiration is close. For example, you can see that the 4 hour chart for VEEV is showing momentum building back to the upside. This is what you want to see if you're going to sell a put option strategy that expires on 9/16.
These are just my thoughts and they are definitely not meant to be trading advice. As always, anything can happen. September can often be a volatile month and is prone to declines. Options trading is risky and can result in complete loss. Trade at your own risk.
If you would like me to post more strategies like this on here leave a boost or a comment below so I can gauge interest. Thank you.
If you're new to trading and don't understand the options trading language that I used above, I would recommend Project Finance to learn about options. I learned a ton about options trading from this channel and the content is always high-quality: www.youtube.com
If you want to learn more about the basics of trading, you can see my post linked below for 10 rules for successful trading.
$VEEV sold covered call 240 $VEEV - everything goes according to plan. We crossed the 200SMA, we might retest back there. There's a huge supply zone around $227-$240 where the stock is struggling today. I own shares and sold covered calls for August 19, 240 strike.
$VEEV looks good VEEV looks good. Above 10,20,50 and 100 MA. 200SMA standing in the way around $234. Nice uptrend for now. Stock is strong.
$VEEV with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $VEEV after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 75%.
VEEV - uptrendAnother stock that seems to have bottomed. 10, 20, 50 MA curled up, it's a lot above 100 MA and I wouldn't be surprised if we retest around $192 and the 100 MA before we grind higher. Also, the 200MA is pretty far away so we might be moving in this range for a bit but overall, the trend looks better than other tech names.
Veeva Solid Buy at $140?Veeva is a technology company that connects pharmaceutical companies with clinical trial sponsors operating under the guise of Salesforce cloud.
Earnings are on June 1st and the stock typically gaps down. Luckily, there is major support going back to 2019 at $137. That would price it at around a 30 forward PE in 2 years. I would like to see it consolidate around $145 to $165 for a few months before moving higher, though it is in a downtrend (blue line). Then, it needs to attack the 50 day EMA (orange line) which was in a death cross with the 200 day moving average (green line) back in November 2021. The bottom of the gap in March 2022 has acted as strong resistance.
VEEV - all covid gains are goneAnother favorite healthcare technology stock of mine. Back to April 2020 levels. Massive 7th month of downtrend. Earnings coming soon. If this doesn't turn its course it's bad and I can see it going to 140-118.
$VEEV with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $VEEV after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 100%.
What a stage 3 top looks like - Stock short idea (VEEV)Some basic rules I have for shorting:
Must be below all key moving averages on the daily time frame - 10d/20d/50d/200dma
Broke down from a stage 3 top or in a stage 4 decline
Basing period / consolidation - the longer the better
Low relative strength rating (not RSI - people mistake the two)
Group/industry must be weak on a relative basis
Ideally earnings and margins are declining
The do-nots:
I do not short stocks because they are "extended"
Never short stocks in stage 1 bases or stage 2 uptrends, nor stage 3 tops until a breakdown is confirmed
Do not short biotech, small caps/low market capitalization - I want to short something that's generally too big to get acquired
Here's a view of VEEV on the daily time frame:
Earnings 3-1 BMOThis one is one of my faves.
I do not feel the timing is right so I sold it last week and it was one of those that hurts a bit to sell. I know I should not get attached to a security, but sometimes I do.
PE is 60.64 and it made me stop and think. Considering the gains, short interest is very low at 1.14%.
This is one I will eyeball and hopefully buy again when I feel a bit safer about the valuation.
No recommendation.
Peak 2 is higher than peak one but this is a monthly chart.
